Elevation Accounts Payable from 2010 to 2025

ELEV Stock  USD 0.70  0.03  4.72%   
Elevation Oncology Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 553.9 K in 2025. Accounts Payable is the amount Elevation Oncology owes to suppliers or vendors for products or services received but not yet paid for. It represents Elevation Oncology's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
583 K
Current Value
553.9 K
Quarterly Volatility
2.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Elevation Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevation Oncology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.3 K, Interest Expense of 5 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.32. Elevation financial statements analysis is a perfect complement when working with Elevation Oncology Valuation or Volatility modules.
  
Check out the analysis of Elevation Oncology Correlation against competitors.
For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.

Latest Elevation Oncology's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Elevation Oncology over the last few years. An accounting item on the balance sheet that represents Elevation Oncology obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Elevation Oncology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Elevation Oncology's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevation Oncology's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Elevation Accounts Payable Regression Statistics

Arithmetic Mean1,495,809
Geometric Mean766,421
Coefficient Of Variation146.31
Mean Deviation1,650,197
Median460,000
Standard Deviation2,188,556
Sample Variance4.8T
Range5.9M
R-Value0.38
Mean Square Error4.4T
R-Squared0.15
Significance0.15
Slope175,080
Total Sum of Squares71.8T

Elevation Accounts Payable History

2025553.9 K
2024583 K
2023507 K
20226.4 M
20215.6 M
20205.7 M

About Elevation Oncology Financial Statements

Elevation Oncology investors use historical fundamental indicators, such as Elevation Oncology's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevation Oncology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable583 K553.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Elevation Stock Analysis

When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.